Detalles de la búsqueda
1.
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
Environ Health;
23(1): 29, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504259
2.
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
J Eur Acad Dermatol Venereol;
37(2): 328-339, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366861
3.
Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study.
Int J Mol Sci;
23(18)2022 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142574
4.
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
BMC Cancer;
21(1): 859, 2021 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34315431
5.
Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease.
Medicina (Kaunas);
57(11)2021 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833378
6.
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci;
20(15)2019 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387256
7.
Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model.
J Cell Mol Med;
22(6): 3073-3085, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29575527
8.
Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.
J Cell Mol Med;
22(6): 3139-3148, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29575535
9.
Targeting YAP in malignant pleural mesothelioma.
J Cell Mol Med;
21(11): 2663-2676, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28470935
10.
Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.
J Cell Mol Med;
19(10): 2385-96, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26218750
11.
Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.
Chemotherapy;
60(3): 201-10, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25871639
12.
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective study.
Aging (Albany NY);
16(1): 550-567, 2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194721
13.
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Thorac Cancer;
15(7): 529-537, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279515
14.
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Ther Adv Med Oncol;
16: 17588359231222604, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249338
15.
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
Vaccines (Basel);
12(5)2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793725
16.
Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports.
Clin Pract;
13(1): 200-205, 2023 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826160
17.
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer.
Thorac Cancer;
14(4): 348-356, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525509
18.
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan.
Thorac Cancer;
14(1): 12-23, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36424878
19.
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.
Thorac Cancer;
14(25): 2548-2557, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525557
20.
Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study.
Am J Cancer Res;
13(8): 3607-3617, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693127